Back to search

Article

Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair

2025-04-09

Abstract excerpt

<h4>ABSTRACT</h4> Human pluripotent stem cell (hPSC)-derived cardiac therapies hold great promise for heart regeneration but face major translational barriers due to allogeneic immune rejection. Here, we engineered hypoimmunogenic hPSCs using a two-step CRISPR-Cas9 strategy: (1) B2M knockout, eliminating HLA class I surface expression, and (2) knock-in of HLA-E or HLA-G trimer constructs in the AAVS1 safe harbor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2c649637-440e-5c08-a7f2-71f3bc0e69ef
DOI
10.1101/2025.04.09.648007
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repairDOI 10.1101/2025.04.09.648007
Select a neighboring publication to make it the new centre.